SCHEMBL7378705

SCHEMBL7378705

CCCC1CCCCc2c1oc(=O)c(Cc1ccccc1C1CC1)c2O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 11/20 0.39
PDE9A O76083 2/20 0.32
NR3C1 P04150 1/20 0.32
GAA P10253 1/20 0.31
MEN1 O00255 1/20 0.30
ABCB11 O95342 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
CYP2C19 P33261 1/20 0.30
KMT2A Q03164 1/20 0.30
PDE4D Q08499 1/20 0.30
PCSK7 Q16549 1/20 0.30
GPR35 Q9HC97 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7350245 0.92 NQO1 (0.40) NQO1NR3C1MEN1ABCB11ALDH1A1
SCHEMBL7351391 0.90 NQO1 (0.37) NQO1NR3C1GAAALDH1A1LMNA
SCHEMBL7360478 0.90 NQO1 (0.37) NQO1
SCHEMBL7356417 0.89 NQO1 (0.36) NQO1NR3C1
SCHEMBL7360324 0.89 NQO1 (0.39) NQO1ALDH1A1
SCHEMBL7355225 0.88 NQO1 (0.40) NQO1MEN1ABCB11ALDH1A1LMNA
SCHEMBL7354427 0.87 NQO1 (0.38) NQO1
SCHEMBL7361349 0.87 NQO1 (0.38) NQO1MEN1KMT2A
SCHEMBL7353426 0.87 NQO1 (0.38) NQO1
SCHEMBL7358122 0.86 NQO1 (0.35) NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0682663-B1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS UPJOHN CO (US) 2001-04-18 EP claimed
WO-1994018188-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS THE UPJOHN COMPANY (US) 1994-08-18 WO disclosed